The mechanism whereby i.p. administration of phosphatidylcholine increases net ultrafiltration and solute clearances after long-dwell exchanges is not established. We performed 4-h exchanges in rats using 4.25% dextrose dialysis solution with and without the addition of 50 mgl L phosphatidylcholine. Net ultrafiltration was enhanced in the treated rats (p < 0.005) by a reduction in cumulative lymphatic absorption (p < 0.01) and without a concurrent increase in total net transcapillary ultrafiltration during the dwell time. Likewise, urea and phosphate clearances with i.p. phosphatidylcholine were enhanced mainly by the increase in the drain volume since serum to dialysate solute concentration ratios did not differ significantly between the treated and control rats. Thus, phosphatidylcholine increases net ultrafiltration and solute clearances in the rat by decreasing lymphatic absorption and without increasing transperitoneal transport of water and solutes into the peritoneal cavity. The uptake of the india ink by the lymphatics of rats who received dialysis exchanges without phosphatidylcholine and the lack of uptake in rats treated with phosphatidylcholine are supported by this observation. Reduction in lymphatic absorption with the addition of phosphatidylcholine to the infused dialysis solution offers an alternative means of enhancing the efficiency of long-dwell peritoneal dialysis.
MactierR.A., KhannaR., TwardowskiZ.Role of peritoneal cavity lymphatic absorption in peritoneal cavity lymphatic absorption in peritoneal dialysis.Kidney Int.1987; 32: 165–172.
7.
NolphK.D., MactierR.A., KhannaR.The kinetics of ultrafiltration in peritoneal dialysis: The role of lymphatics.Kidney Int.1987; 32: 219–226.
8.
MactierR.A., KhannaR., TwardowskiZ.Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in CAPD.J Clin Invest.1987; 80: 1311–1316.
9.
CunninghamR.S.Studies in absorption from serous cavities IV. On the passage of blood cells and particles of different size through the walls of the lymphatics in the diaphragm.Am J Physiol.1922; 62: 248–252.
10.
Measuring albumin concentrations with Spectru BCG.Methods brochure, Pierce Chemical Co., Rockford, Illinois, 1978.
11.
Glucose concentrations by an O-toluidine method. Sigma Technical Bulletin #635. Sigma Chemical CompanySt. Louis, Missouri, 1977.
12.
LillS.R., ParsonsR.H., BohacI.Permeability of the diaphragm and fluid resorption from the peritoneal cavity in the rat.Gastroenterology.1979; 76: 997–1001.
13.
AuneS.Transperitoneal exchange IV. The effect of transperitoneal fluid transport on the transfer of solutes.Scand J Gastroenterol.1970; 5: 241–252.
14.
CourticeF.C., SteinbeckA.W.Absorption of protein from the peritoneal cavity.J Physiol.1951; 114: 336–355.
15.
HenriksenJ.H., LassenN.A., ParvingH.Filtration as the main transport mechanism of protein exchange between plasma and the peritoneal cavity in hepatic cirrhosis.Scand J Clin Lab Invest.1980; 40: 503–513.
16.
IndraprasitS., SooksriwongseC.Effect of chlorpromazine on peritoneal clearances.Nephron.1985; 40: 341–343.
17.
GruskinA.B., CoteM.L., BaluarteH.J.Peritoneal diffusion curves, peritoneal clearances and scaling factors in children of differing age.Int J Ped Nephrol.1982; 3: 271–278.
HambrichD.R., ChippendaleT.J.Regulation of acetylcholine synthesis in nervious tissue.Life Sci.1977; 20: 1465–1478.
20.
HirschM.J., UlusI.H., WurtmanR.J.Elevation of brain and adrenal acetylcholine levels and of adrenal tyrosine hydroxylase activity following administration of choline via stomach tube.Neurosci Abstr.1976; 2: 765.
21.
CohenE.L., WurtmanR.J.Brain acetylcholine: Control by dietary choline.Science.1976; 191: 561–562.
22.
MorleyB.J., RobinsonG.R., BrownG.B.Effect of dietary choline on nicotinic acetylcholine receptors in brain.Nature.1977; 266: 848–859.
23.
UlusI.H., WurtmanR.J.Choline administration: Activation of tyrosine hydroxylase in dopaminerigic neurons of rat brain.Science.1976; 194: 1060–1061.
24.
FannW.E., LakeC.R., GerberC.T.Cholinergic sup pression of tardive dyskinesia.Psychopharmacologia.1974; 37: 101–107.
JacksonI.V., DavisL.G., CohenR.K.Lecithin admin istration in tardive dyskinesia: Clinical and biomedical correlates.Biol Psychiatry.1981; 16: 85–89.
27.
PentlandB., MartynC.N., SteerC.R.Lecithin treatment in Friedreich's ataxia.Br Med J.1981; 282: 1197–1198.
28.
EtienneP., GauthierS., DastoorD.Alzheimer's disease: Clinical effect of lecithin treatment. In: BarbeauA.., eds. Nutrition and the brain.New York: Raven Press, 1979: 389–396.
29.
DrachmanD.A., SahakianB.J.Effects of cholinergic agents on human learning and memory. In: BarbeauA.., eds. Nutrition and the brain.New York: Raven Press, 1979: 351–366.
30.
SitaramN., WeingartnerH., Christian GillinJ.Choline chloride and arecholine: Effects on memory and sleep in man. In: BarbeauA.., eds. Nutrition and the brain.New York: Raven Press, 1979: 367–376.
31.
HarrisC.M., DavisJ.M., JanowskyD.S.Use of cholinergic drugs in mental illness. In: BarbeauA.., eds. Nutrition and the brain.New York: Raven Press, 1979: 397–408.
32.
TammingaC.A., NuttJ.G.Cholinergic influences on affect. In: BarbeauA.., eds. Nutrition and the brain.New York: Raven Press, 1979: 409–416.
33.
MactierR.A., KhannaR., MooreH.Pharmacological reduction of lymphatic absorption from the peritoneal cavity increases net ultrafiltration and solute clearances in peritoneal dialysis.Nephron. (in press).
34.
LeakL.V.Distribution of cell surface charges on mesothelium and lymphatic endothelium.Microvasc Res.1986; 31: 18–30.
35.
LeakL.V.: Studies on the permeability of lymphatic cap illaries.J Cell Biol.1971; 50: 300–323.
36.
Di PaoloN., SacchiG., De MiaM.Morphology of the peritoneal membrane during peritoneal dialysis.Nephron.1986; 44: 204–211.
37.
DobbieJ.W., ZakiM., WilsonL.Ultrastructural studies on the peritoneum with special reference to chronic ambulatory peritoneal dialysis.Scott Med J.1981; 26: 213–223.
38.
VergerC., BrunschviggO., Le CarpentierY.Structural and ultrastructural peritoneal membrane changes and permeability alterations during CAPD.Proc Eur Dial Transplant Assoc.1981; 18: 199–203.
39.
WideroeT.E., SmebyL.C., MjaalandS.Long-term changes in transperitoneal water transport during continuous ambulatory peritoneal dialysis.Nephron.1984; 38: 238–247.
40.
SlingeneyerA., CanaudB., MionC.Permanent loss of untrafiltration capacity of the peritoneum in long-term peritoneal dialysis: An epidemiological study.Nephron.1983; 33: 133–138.
41.
FallerB., MarichalJ.F.Loss of ultrafiltration in continuous ambulatory peritoneal dialysis: A role for acetate.Perit Dial Bull.1984; 4: 10–13.
42.
OreopoulosD.G.Duration of peritoneal dialysis-ten years or more.Perit Dial Bull.1984; 4: 61–62.
OtaK., MineshimaM., WatanabeN.Functional deterioration of the peritoneum: Does it occur in the \absence of peritonitis?Nephrol Dial Transplant.1987; 2: 30–33.
45.
MistryC.D., MallickN.P., GokalR.Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges.Lancet.1987; 2: 178–182.
46.
TwardowskiZ.J., NolphK.D., KhannaR.Charged polymers as osmotic agents for peritoneal dialysis.Materials Research Society Symposium Proceedings.1986; 55: 319–326.
47.
LindbladA.S., NovakJ.W., StableinD.M.Characteristics of participants and selected outcome measures of the period January 1, 1981 through August 31, 1986. Report of the National CAPD Registry of the National Institutes of Health, 1987.
